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Summary
A complex of polypeptides derived from a precursor is present on the surface of the malaria
merozoite. During erythrocyte invasion only a small fragment from this complex is retained
on the parasite surface and carried into the newly infected red cell . Antibodies to this fragment
will interrupt invasion .
P
roteins on the surface of malaria merozoites are targets
of an immune response and are candidate vaccine com-
ponents. The precursor to major merozoite surface antigens,
referred to here as MSP1(merozoite surface protein 1) is syn-
thesized during schizogony and is present on the merozoite
as a complex of fragments derived by proteolytic processing
(1, 2) . An 83-kD fragment, MSP183 can be isolated from
culture supernatants, and mAbs specific for MSP183 do not
react with newly invaded (ring-stage) parasitized erythrocytes
in an immunofluorescence (IF) assay (2-3), suggesting that
this part of the complex is shed during the invasion process .
A second group ofMSP1-mAb do react in IF with ring forms,
and all appear to react with reduction-sensitive epitopes on
a COOH-terminal 42-45-kD fragment (MSP142) and a
16-19-kD polypeptide subfragment (MSP1 19) from the
cysteine-rich COOH terminus ofthe precursor (2, 4-6) . There
is evidence that a MSP1-specific immune response can pro-
tect against blood-stage challenge (1, 7), and certain mAbs
to either the Plasmodium falciparum MSPI or homologues in
other species have been shown to inhibit the growth of the
parasite in vitro (8-9) or protect on passive transfer in vivo
(10-12) . The function ofMSP1 is unknown, although it may
be involved in red cell invasion, possibly in a receptor role (13) .
Here we demonstrate that MSP19 is specifically carried
into the red cell and that antibodies to this fragment can in-
hibit invasion. These observations suggest that processing




MSPl-specific mAbs were used: 12.1 and 13.2 (anti-
MSPls3); 13 .1 and X509 (anti-MSP1 42 N-terminus) ; 7.5, 12.8, and
12.10 (anti-MSP1 42 COOH terminus and MSPl l9) (2) . mAb 13.4
(anti-MSP2, merozoite surface protein 2, 46-kD antigen) and 13.3
(anti-lactate dehydrogenase) were used as controls (14) . X509 is
a product of a human EBVtransformed cell line derived from a
Gambian donor (Blackman,M .J ., et al ., manuscript in preparation) .
Parasites.
￿
P . falciparum, strain FCB-1, and clones T9/94 and
T9/96 were maintained essentially as describedpreviously (3), and




P .fkiparum (FCB-1 strain) cultures
-1 h after invasion and containing 50-60% ring forms were fixed,
cryosectioned and incubated with ascitic fluid containing themAbs .
Antibody binding was revealed by incubation with rabbit anti-
mouse Ig and protein A-gold . After washing in PBS, sections were
stained with 2% uranyl acetate and viewed in aJEOL l00B elec-




harvested at 1-1.5 h intervals from cultures enriched for schizonts
(85-90% parasitaemia at a hematocrit of-0.2%) and washed in
PBS containing the following protease inhibitors : 1 mM PMSF,
2mM tosyl-L-lysine chloromethyl ketone (TLCK), 0.1 mM tosyl-
L-phenylalanine chloromethyl ketone (TPCK), and chymostatin,
leupeptin, antipain, and aprotinin (all at 10 hg/ml) .
To prepare ring-stages, schizonts were cultured in the presence
of fresh, washed erythrocytes at 2% hematocrit (15-20% para-
sitaemia). After 7 h the cells were centrifuged twice over 67.5%
isotonic Percoll to remove any remaining schizonts . The resulting
pellets containing only uninfected erythrocytes and ring-stage para-
sites (with <0.01% schizont contamination) were washed twice
in serum-free medium and resuspended in ice-cold PBS containing
protease inhibitors (PBS/PI) . Saponin (10% wt/vol in PBS, BDH
Ltd ., Poole, UK) was added slowly with gentle mixing to a final
concentration of 0.005%, and the suspension was incubated on
ice until lysis began . An equal volume of PBS/PI was added, and
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￿
Immunoelectron micrographs of newly formed P . .fal-
ciparum ring-stages in freshly invaded erythrocytes labeled with the
mAbs (a) 7.5 (1 h after invasion), (b) 7.5 (2 h after invasion), (c)
12 .10, (d) 12 .8, (e) 12.10 13 .1, and (g) 13.4, or (b) with ascites
fluid . The antibodies are directed against MSP119 (a-d), MSP183 (e),
the NH2-terminal end of MSP142 (f), and to MSP2 (g) . Bars, 0.5
pm.
then the parasites and red cell membranes were pelleted by cen-
trifugation at 15,000g for 15 min at4°C. Aftertwo further washes
pellets were solubilized directly intoSDS sample buffer for analysis
by SDS-PAGE and immunoblotting .
Metabolic Labeling and Immunoprrcipftation.
￿
Synchronous cultures
containing 30-35-h-old trophozoites (6% hematocrit, 10% para-
sitetrtia) were incubated incysteme-freecomplete medium containing
1.85 MBq/ml [35S]cysteine (>37 TBq/mmol, Amersham Interna-
tional plc, Amersham, UK).The cultures were diluted with com-
pletemedium 2 and 12h later and mature schizontswere purified
over 63% Percoll, washed three times inwarm serum-free medium,
then divided into two cultures in normal complete medium. One
culturewas used to produce merozoites, the otherwassupplemented
with fresh erythrocytes to produce ring-stages. The parasites were
harvested, frozen at -70°C, and then thawed directly into lysis
buffer (50mM Tris-HCI, pH 8.2, containing 5MM EDTA, 5mM
EGTA, 0.5% wt/vol sodiumdeoxycholate, andsupplemented with
the protease inhibitors leupeptin, aprotinin, PMSF, and TLCK) .
Labeled proteins were immunoprecipitated and analyzed by
SDS-PAGE .
Merozoite Invasion Inhibition Test.
￿
Synchronous parasites (T9-
94 andT9-96 clones) at tit% schizont parasitemia were cultured
in triplicate in medium supplemented with purified Ig (14) . 24 h
later the number of ring-stage parasites was counted in Giemsa-
stained thin film smears.
Results
The presence of antigens in newly invaded parasites was
studiedby immunoelectron microscopy (immunoEM) (Fig.
1) . The three mAbs specific for MSP1 t9 reacted with the
parasite membrane ofnewlyformed ring stages (Fig. 1, a-d) .
mAbs specific for MSP183 (Fig. 1 e) or the NH2-terminal
part of MSP142 (Fig. 1 f) did not react, nor did a mAb
reacting withMSP2 (Fig. 1g) .mAb 7.5 reacted better with
ring-stages 1 h after invasion than those 2 h after invasion
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Malaria Merozoite Protein Processing
Figure 2 .
￿
Reactivity of mAbs with extracts of either merozoites
(lanes 1, 3, and 5) or early ring-stages (lanes 2, 4, and 6) ofP . faki-
parum clone T9-96 . The lysates were electrophoresed on a 7.5-15%
polyacrylamide gel, transferred to nitrocellulose, and then probed
with either mouse rnAb 12 .8 (lanes 1 and 2), mouse mAbs 12.8 t
12 .1 (lanes 3 and 4), or human mAb X509 (lanes 5 and 6) . The
position of standard molecular weight markers is indicated .
and did not react with older parasites, suggesting that the
antigen subsequently disappeared.
To investigate the fate of differentMSP1 fragments during
invasion, lysates of merozoites and ring-stages were probed
by immunoblotting. mAb 12.8 reacted with both MSP142
(39 kD under nonreducing conditions) and MSP1i9 in
Figure 3.
￿
mAb 12.8 immunoprecipitation of proteins labeled with
[3$S]cysteine in schizonts and present in subsequent merozoite (lanes 1
and 3) and ring (lanes 2 and 4) stages . Immunoprecipitates were dis-
solved in SDS sample buffer in the absence (lanes 1 and 2) or pres-
ence (lanes 3 and 4) of mercaptoethanol and electrophoresed on a
10-15% polyacrylamide gel. Labeled polypeptides were detected by


































Merozoite invasion inhibited in vitro by mAb 12.10.
Schizonts of P. fakiparum clones T9-94 (left) or T9-96 (right) at a
starting parasitemia of 1% were incubated in the presence of mAb
12.10 or a control mouse IgG1 (mAb 13.3). After invasion, N4%
(mean ± SD) ring-stage parasites were present in control cultures.
merozoite extracts (Fig. 2, lane 1), but only MSP119 was de-
tected in ring-stages (lane 2). A mixture of mAbs 12.8 and
12.1 reacted additionally with MSP183 in merozoites (lane 3),
but this fragment could not be detected in ring-stages (lane
4). X509 (specific for the NH2 terminus of MSP142) reacted
with a doublet in merozoites but did not react with ring-
stages (lanes 5 and 6).
To confirm that the 12.8-reactive 19-kD species in rings
was derived from the invading merozoite, schizonts were la-
beled with [35S]cysteine, allowed to develop to merozoites or
young ring-stages (no more than 8 h old) and then cell ex-
tracts were used in immunoprecipitation experiments. Fig.
3 shows that mAb 12.8 precipitated labeled MSP119 from
ring-stages (lanes 2 and 4), but the MSP142 present in ex-
tracts of labeled merozoites (lanes 1 and 3) was not in the
ring-stage preparations. Similar results were obtained using
material labeled with tritiated isoleucine, leucine, and valine
(data not shown). These data indicate that the 19-kD species
present in ring-stages is taken in with the invading merozoite,
and not synthesized de novo after invasion.
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Merozoite invasion was inhibited by mAbs 12.8 and 12.10,
specific for MSP119. Fig. 4 shows the inhibition relative to
a control Ig using mAb 12.10 and two different parasite strains.
At 500 Ag/ml the antibody inhibited invasion by 72% (T9-
94 strain) and 50% (T9-96 strain), respectively.
We have used mAbs to trace some of the MSP1 fragments
during erythrocyte invasion. Only MSP119 is detectable in
the newly invaded red cell; mAbs specific for the NH2 ter-
minus of MSP142 do not react by IF and immunoEM, and
MSP142 could not be detected by immunoblotting or immu-
noprecipitation. The ring-stage MSP119 is indistinguishable
from that on the merozoite surface and has been shown by
metabolic labeling to be derived from the invading merozoite.
Since MSPI may be membrane-bound by a glycosyl phos-
phatidylinositol anchor (16) this is presumably intact on ring-
stage MSP119. MSP142 to MSP119 processing appears to
occur, at least in part, at erythrocyte invasion and is intrinsic
to this process. Some but not all merozoites isolated have
MSPl-derived fragments that have already undergone the
MSP142 to MSP119 processing, and therefore, this step can
occur before invasion; the cleavage may be triggered by in-
teraction ofthe free merozoite with erythrocyte surface com-
ponents; alternatively, the presence of MSP119 in merozoite
extracts may be partly or wholly artefactual, resulting from
proteolysis during the isolation procedure. Certainly, different
methods of merozoite isolation result in differing relative
amounts of MSP142 and MSP119 (see e.g., reference 2). The
apparent specificity and reproducibility of the proteolysic
cleavage suggest that this process is an integral part of the
asexual blood-stage cycle.
We have shown that antibodies to conserved epitopes on
P. falciparum MSP119 (albeit at high concentration) can in-
hibitred cell invasion. Recently it has been shown that a mAb
protective on passive transfer against P. yoelii (10) is directed
against the homologous MSP1 cysteine-rich domain (17).
These findings suggest that an antibody response to MSP119
may interrupt the malaria asexual blood stage cycle.
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